Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 3 |
2022 | 1 |
2023 | 1 |
2024 | 2 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Conflict of Interest Disclosures.
Global Spine J. 2024 May;14(4_suppl):690S-714S. doi: 10.1177/21925682241245615.
Global Spine J. 2024.
PMID: 38726630
Free PMC article.
No abstract available.
Impact of KRASG12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes.
Caballé-Perez E, Hernández-Pedro N, Ramos-Ramírez M, Barrios-Bernal P, Romero-Núñez E, Lucio-Lozada J, Ávila-Ríos S, Reyes-Terán G, Cardona AF, Arrieta O.
Caballé-Perez E, et al.
Clin Transl Oncol. 2024 Apr;26(4):836-850. doi: 10.1007/s12094-023-03279-2. Epub 2023 Jul 25.
Clin Transl Oncol. 2024.
PMID: 37490263
Free PMC article.
Item in Clipboard
IgG antibodies reacting with ghrelin and leptin are correlated with body composition and appetitive traits in young subjects.
Espinoza-García AS, Hunot-Alexander C, Martínez-Moreno AG, Vázquez-Solorzano R, Porchas-Quijada M, Reyes-Castillo Z.
Espinoza-García AS, et al.
Appetite. 2022 Jan 1;168:105685. doi: 10.1016/j.appet.2021.105685. Epub 2021 Sep 7.
Appetite. 2022.
PMID: 34506856
Free article.
Item in Clipboard
A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles.
Gimenez AM, Salman AM, Marques RF, López-Camacho C, Harrison K, Kim YC, Janse CJ, Soares IS, Reyes-Sandoval A.
Gimenez AM, et al.
Sci Rep. 2021 Sep 9;11(1):17928. doi: 10.1038/s41598-021-96986-1.
Sci Rep. 2021.
PMID: 34504134
Free PMC article.
Item in Clipboard
A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial.
Folegatti PM, Harrison K, Preciado-Llanes L, Lopez FR, Bittaye M, Kim YC, Flaxman A, Bellamy D, Makinson R, Sheridan J, Azar SR, Campos RK, Tilley M, Tran N, Jenkin D, Poulton I, Lawrie A, Roberts R, Berrie E, Rossi SL, Hill A, Ewer KJ, Reyes-Sandoval A.
Folegatti PM, et al.
Nat Commun. 2021 Jul 30;12(1):4636. doi: 10.1038/s41467-021-24906-y.
Nat Commun. 2021.
PMID: 34330906
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite